← Leaderboards
Ronald T Borchardt
University Of Kansas Lawrence
$5,030,359
Attributed
$5,030,359
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $554.3K · FY2005–07$1M$750K$500K$250K$0
'05
'06
'07
Funding mix
By agency
NIH$5,030,359 · 4
By mechanism
R01$4,610,751 · 3
T32$419,608 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Kansas Lawrence
Same institution · by research overlap
- Susan M Lunte$16,458,643
- Fusao None Takusagawa$784,873
- Qi-Zhuang Ye$3,627,989
Others in their field
Top investigators on “Blood Brain Barrier”
- Berislav V Zlokovic · University Of Rochester$46,148,415
- Michal J. Toborek · University Of Kentucky$31,822,434
- Edward A Neuwelt · Oregon Health And Science University$27,712,098
- Yuri Persidsky · Temple Univ Of The Commonwealth$26,469,363
- Joan Weinberger Berman · Yeshiva University$21,803,760
- Katerina Akassoglou · University Of California San Diego$19,086,450
Research focus
Blood Brain BarrierDrug Design /Synthesis /ProductionP GlycoproteinIntestinal MucosaMembrane PermeabilityLaboratory RatSynthetic PeptidePharmacokineticsPeptide Chemical SynthesisConformationMembrane Transport ProteinsX Ray CrystallographySite Directed MutagenesisHydrolaseHomocysteineOpioid ReceptorNicotinamide Adenine DinucleotideProdrugsEnzyme InhibitorsChemical StabilityTissue /Cell CultureIndinavirOligopeptidesPeptide Analog
Grant awards (20)
Cyclic Prodrugs of Opioid Peptides$241,431
R01 · FY2007 · DA · contact PI
AdoHcy Hydrolase Inhibitors as Antiparasitic Agents$292,246
R01 · FY2006 · GM · contact PI
Cyclic Prodrugs of Opioid Peptides$248,642
R01 · FY2006 · DA · contact PI
AdoHcy Hydrolase Inhibitors as Antiparasitic Agents$299,680
R01 · FY2005 · GM
Cyclic Prodrugs of Opioid Peptides$254,625
R01 · FY2005 · DA
AdoHcy Hydrolase Inhibitors as Antiparasitic Agents$299,680
R01 · FY2004 · GM
Cyclic Prodrugs of Opioid Peptides$254,625
R01 · FY2004 · DA
AdoHcy Hydrolase Inhibitors as Antiparasitic Agents$309,690
R01 · FY2003 · GM
Cyclic Prodrugs of Opioid Peptides$254,625
R01 · FY2003 · DA
TRANSPORT CHARACTERISTICS OF PEPTIDE MIMETICS$168,605
R01 · FY2003 · GM
ADOHCY HYDROLASE: STRUCTURE, MECHANISM, INHIBITOR DESIGN$248,703
R01 · FY2002 · GM
TRANSPORT CHARACTERISTICS OF PEPTIDE MIMETICS$245,623
R01 · FY2002 · GM
ADOHCY HYDROLASE: STRUCTURE, MECHANISM, INHIBITOR DESIGN$296,751
R01 · FY2001 · GM
TRANSPORT CHARACTERISTICS OF PEPTIDE MIMETICS$238,555
R01 · FY2001 · GM
CYCLIC PRODRUGS OF OPIOID PEPTIDES$228,866
R01 · FY2001 · DA
PHARMACEUTICAL ASPECTS OF BIOTECHNOLOGY TRAINING$216,024
T32 · FY2001 · GM
ADOHCY HYDROLASE: STRUCTURE, MECHANISM, INHIBITOR DESIGN$274,511
R01 · FY2000 · GM
TRANSPORT CHARACTERISTICS OF PEPTIDE MIMETICS$231,692
R01 · FY2000 · GM
CYCLIC PRODRUGS OF OPIOID PEPTIDES$222,201
R01 · FY2000 · DA
PHARMACEUTICAL ASPECTS OF BIOTECHNOLOGY TRAINING$203,584
T32 · FY2000 · GM